Copertina

The role of stress in the comorbidity of migraine and other chronic primary pain

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shi‐Jie Zhao, Ting‐Ting Wang, Qi Zhang, Simon Akerman, Dong‐Yuan Cao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study
di: Kuang‐Heng Lee, et al.
Pubblicazione: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
di: Haley C. Cropper, et al.
Pubblicazione: (2024)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
di: Baicheng Cao, et al.
Pubblicazione: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
di: Shuu‐Jiun Wang, et al.
Pubblicazione: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
di: Nan Cheng, et al.
Pubblicazione: (2025)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
di: Marina Vives‐Mestres, et al.
Pubblicazione: (2024)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
di: Alexander Yoo, et al.
Pubblicazione: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
di: Kara S. Graves, et al.
Pubblicazione: (2026)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
di: Christopher C. Anderson, et al.
Pubblicazione: (2024)

The association between posttraumatic stress disorder and migraine: A systematic review
di: Lucie Nitsche, et al.
Pubblicazione: (2026)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
di: Brooke L. Reidy, et al.
Pubblicazione: (2025)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
di: Alexis Espanioli, et al.
Pubblicazione: (2025)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
di: Philip Victor Reducha, et al.
Pubblicazione: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
di: Andrew Blumenfeld, et al.
Pubblicazione: (2024)

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
di: Marta Pascual‐Mato, et al.
Pubblicazione: (2024)

Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine
di: Marie Raquin, et al.
Pubblicazione: (2025)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
di: Ghader Mohammadnezhad, et al.
Pubblicazione: (2024)

Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia
di: Elizaveta Ermakova, et al.
Pubblicazione: (2024)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
di: Anna de Dios, et al.
Pubblicazione: (2024)

Investigating the causal and genetic relationship between migraine and Parkinson's disease
di: Ming‐Gang Deng, et al.
Pubblicazione: (2024)

Serum levels of autotaxin reveal its role as a novel biomarker of migraine
di: Alberto Ouro, et al.
Pubblicazione: (2025)

The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis
di: Scott W. Kirkland, et al.
Pubblicazione: (2024)

Association between obstructive sleep apnea and migraine: A United States population‐based cohort study
di: Thomas Yen‐Ting Chen, et al.
Pubblicazione: (2025)

Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
di: Matteo Conti, et al.
Pubblicazione: (2024)

Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case–control study
di: Gerlinde Freimark, et al.
Pubblicazione: (2025)

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
di: Rebecca Lindsay, et al.
Pubblicazione: (2024)

Do antithrombotic drugs have a role in migraine prevention? A systematic review
di: Federico De Santis, et al.
Pubblicazione: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
di: Meesha Trivedi, et al.
Pubblicazione: (2024)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Pubblicazione: (2025)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
di: Samantha C. Shao, et al.
Pubblicazione: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
di: Joaquín Borrás‐Blasco, et al.
Pubblicazione: (2025)

Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease
di: Ming‐Gang Deng, et al.
Pubblicazione: (2025)

Lessons from the coronavirus disease 2019 pandemic: Investigating the bidirectional relationship between coronavirus disease 2019 and migraine based on the MECH‐HK cohort study
di: Jingbo Liang, et al.
Pubblicazione: (2025)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Evaluating associations of migraine‐related vertigo
di: Nazia Karsan, et al.
Pubblicazione: (2025)

A machine learning‐driven transcriptomic study reveals the key role of Romo1 in reversing central sensitization through stellate ganglion block in migraine: An interventional study based on a recurrent migraine rat model
di: Fei Yang, et al.
Pubblicazione: (2025)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
di: Tzu‐Hsuan Su, et al.
Pubblicazione: (2024)